Robuta

https://www.nice.org.uk/guidance/indevelopment/gid-ta11613 Project information | Cabozantinib for treating advanced neuroendocrine tumours that have... Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474] project informationneuroendocrine tumourscabozantinibtreatingadvanced https://www.brunel.ac.uk/IamBrunel/profile?entryId=4f0d3050-6e33-e662-a54e-457db26b116d Franchise Marketing Intern within Neuroendocrine Tumours and Renal-Cell Carcinoma Biomedical science placement franchise marketingneuroendocrine tumoursinternwithinrenal https://pmc.ncbi.nlm.nih.gov/articles/PMC4952131/ Nuclear medicine imaging of neuroendocrine tumours - PMC nuclear medicine imagingneuroendocrine tumourspmc https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/somatostatin-analogues-for-neuroendocrine-tumours-nets Somatostatin analogues for neuroendocrine tumours (NETs) | Macmillan Cancer Support Somatostatin analogues (SSAs) are drugs that treat the symptoms of carcinoid syndrome. They can help reduce diarrhoea and flushing whilst slowing tumour growth. neuroendocrine tumoursmacmillan cancersomatostatinanaloguesnets https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment/somatostatin-analogue-drugs Somatostatin analogues for neuroendocrine tumours | Cancer Research UK Somatostatin analogues are drugs that stop your body from making too many hormones. They are a possible treatment for some neuroendocrine tumours (NETs). neuroendocrine tumourscancer researchsomatostatinanaloguesuk https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment/tae Trans arterial embolisation (TAE) for neuroendocrine tumours (NETs) | Cancer Research UK TAE is a treatment for neuroendocrine tumours (NETs) that spread to the liver. It means having a substance such as a gel or tiny beads to block the blood... neuroendocrine tumourscancer researchtransarterialembolisation https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-lanreotide-autogel-for-neuroendocrine-tumours-of-the-digestive-system-that-have-spread A trial looking at lanreotide autogel for neuroendocrine tumours of the digestive system that have... This trial looked at a drug called lanreotide autogel to stop or slow the growth of neuroendocrine tumours (NETs). https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-everolimus-for-neuroendocrine-tumours-of-the-pancreas-oblique A study looking at everolimus for neuroendocrine tumours of the pancreas (The OBLIQUE study) This study is to find out more about the drug everolimus (also known Afinitor) as a treatment for neuroendocrine tumours of the pancreas. a studylooking at https://www.cancerresearchuk.org/about-cancer/treatment/radioisotopes/131-i-mibg Radioactive iodine MIBG (131 I-MIBG) for neuroendocrine tumours (NETs) | Cancer Research UK 131 I-MIBG is a type of radioisotope therapy. It uses radioactive iodine attached to a substance called MIBG. It is a possible treatment for NETs. radioactive iodine https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-the-immune-system-for-people-with-neuroendocrine-tumours-immunet A study looking at the immune system for people with neuroendocrine tumours (IMMUNET) This study is trying to understand more about how the immune system works in people with a neuroendocrine tumour (NET). the immune system https://www.livingwithnets.com/ Living with NETs: For people with neuroendocrine tumours (NETs) Jun 27, 2022 - Living with NETs provides information and support for people with neuroendocrine tumours (NETs) from diagnosis to treatment and living with NETs long term. living with netsfor peopleneuroendocrinetumours https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-of-lanreotide-for-neuroendocrine-tumours-of-the-pancreas-or-small-bowel-that-have-spread A study of lanreotide for neuroendocrine tumours of the pancreas or small bowel that have spread... This study is for people with a neuroendocrine tumour that started in the pancreas or small bowel (duodenum) and cannot be removed with surgery.